Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Checkpoint Inhibitors”

705 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 705 results

Not applicableEnded earlyNCT05699915
What this trial is testing

Extensive CArdioVAscular Characterization and Follow-up of Patients Receiving Immune Checkpoint Inhibitors

Who this might be right for
CancerImmune-related Adverse EventCardiac Abnormalities, Variable+4 more
Algemeen Ziekenhuis Maria Middelares 105
Testing effectiveness (Phase 2)Looking for participantsNCT06249750
What this trial is testing

Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (CRPC)
Pengyuan Liu 60
Not applicableUnknownNCT04107168
What this trial is testing

Microbiome Immunotherapy Toxicity and Response Evaluation

Who this might be right for
MelanomaRenal CancerLung Cancer
CCTU- Cancer Theme 1,800
Not applicableLooking for participantsNCT06132984
What this trial is testing

Cardiac Magnetic Resonance Monitoring of Immune Checkpoint Inhibitor-related Cardiotoxicity

Who this might be right for
Immune Checkpoint Inhibitors, Cardiotoxicity
West China Second University Hospital 22
Testing effectiveness (Phase 2)UnknownNCT04826406
What this trial is testing

Camrelizumab Combined Apatinib in Hepatocellular Carcinoma Previously Treated With Immune Checkpoint Inhibitors (ICIs).

Who this might be right for
Hepatocellular CarcinomaImmune Checkpoint Inhibitors
Hunan Cancer Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT04954599
What this trial is testing

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Maastricht University Medical Center 126
Early research (Phase 1)Looking for participantsNCT04038619
What this trial is testing

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

Who this might be right for
ColitisDiarrheaMalignant Genitourinary System Neoplasm+6 more
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07269158
What this trial is testing

A Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract NeoplasmsAdvanced CancerImmunotherapy
Yonsei University 160
Testing effectiveness (Phase 2)Looking for participantsNCT05801133
What this trial is testing

Pifenidone Prophylactic Therapy for Radiation Lung Injury in Patients Who Have Previously Received Immune Checkpoint Inhibitors

Who this might be right for
Lung Cancer
Hubei Cancer Hospital 41
Not applicableNot Yet RecruitingNCT05834413
What this trial is testing

Clinical Study on the Prevention of Driver Gene Negative II-IIIa Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors

Who this might be right for
Lung Cancer
Shanghai University of Traditional Chinese Medicine 367
Post-approval studies (Phase 4)Not Yet RecruitingNCT07004335
What this trial is testing

Efficacy and Safety of Iparomlimab and Tuvonralimab Injection in Combination With Bevacizumab After Progression on Anti-PD-(L)1 Therapy in Advanced Melanoma: A Prospective, Single-Arm, Exploratory Clinical Study

Who this might be right for
PD-(L)1CTLA-4Advanced Melanoma+3 more
Hebei Medical University Fourth Hospital 40
Testing effectiveness (Phase 2)UnknownNCT05438108
What this trial is testing

SBRT Sequential CapeOX Regimen Combined With Bevacizumab and Sintilimab in First-line Treatment of mCRC

Who this might be right for
Metastatic Colorectal Cancer
Huazhong University of Science and Technology 30
Testing effectiveness (Phase 2)Looking for participantsNCT07213830
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies

Who this might be right for
Advanced Solid TumorMetastatic Solid Tumor
Ipsen 102
Testing effectiveness (Phase 2)Study completedNCT04694183
What this trial is testing

The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer

Who this might be right for
Stomach Neoplasms
Quan Wang 37
Not applicableActive Not RecruitingNCT06630429
What this trial is testing

A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors

Who this might be right for
Non-Small Cell Lung CancerRenal Cell Carcinoma (RCC)
Ohio State University Comprehensive Cancer Center 100
Not applicableLooking for participantsNCT06635954
What this trial is testing

A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications.

Who this might be right for
CancerImmunotherapyPD-1+2 more
Oxford Biodynamics Inc. 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT06819735
What this trial is testing

Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Domain Therapeutics Australia Pty Ltd 125
Not applicableLooking for participantsNCT04892849
What this trial is testing

Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy

Who this might be right for
HNSCCNSCLCEsophageal Cancer+4 more
University of Erlangen-Nürnberg Medical School 200
Not applicableActive Not RecruitingNCT03695952
What this trial is testing

A Prospective Cohort Study of Patients with Hepatobiliary Cancer Treated with Immune Checkpoint Inhibitors

Who this might be right for
Hepatocellular CarcinomaBiliary Tract Cancer
Asan Medical Center 100
Large-scale testing (Phase 3)Looking for participantsNCT06794775
What this trial is testing

SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Melanoma

Who this might be right for
Malignant Melanoma Stage III
Hildur Helgadottir 128
Load More Results